Reitmans Limited (TSE:RET – Get Free Report) Senior Officer Richard Wait sold 24,600 shares of the company’s stock in a transaction that occurred on Friday, November 1st. The stock was sold at an average price of C$2.66, for a total value of C$65,436.00.
Richard Wait also recently made the following trade(s):
- On Wednesday, October 30th, Richard Wait sold 10,100 shares of Reitmans stock. The shares were sold at an average price of C$2.68, for a total value of C$27,068.00.
- On Monday, September 30th, Richard Wait sold 10,000 shares of Reitmans stock. The shares were sold at an average price of C$2.54, for a total value of C$25,400.00.
- On Friday, September 27th, Richard Wait sold 20,000 shares of Reitmans stock. The stock was sold at an average price of C$2.50, for a total value of C$50,000.00.
Reitmans Price Performance
Reitmans Limited has a 1-year low of C$0.18 and a 1-year high of C$3.15. The company has a debt-to-equity ratio of 188.87, a quick ratio of 0.26 and a current ratio of 1.10. The stock’s fifty day simple moving average is C$0.27. The company has a market capitalization of C$13.19 million and a price-to-earnings ratio of -0.09.
Reitmans Company Profile
Reitmans (Canada) Limited primarily engages in the retail of women's wearing apparel in Canada. Its products include shirts, blouses, pants, dresses, skirts, sweaters, outerwear, activewear, lingerie, and accessories. The company also offers apparel for men. It serves customers through retail and e-commerce channels, under the Reitmans, Addition Elle, Penningtons, RW & CO., Thyme Maternity, and Hyba brand names.
Featured Stories
- Five stocks we like better than Reitmans
- Transportation Stocks Investing
- Intel: Is Now the Time to Be Brave?Â
- What is Short Interest? How to Use It
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Manufacturing Stocks Investing
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Reitmans Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reitmans and related companies with MarketBeat.com's FREE daily email newsletter.